Alfalfa.

Alfalfa leaf is a dense source of vitamin K1. Vitamin D drives transcription of osteocalcin and related calcium-binding proteins, and vitamin K supplies the carboxylation step that makes those proteins functional, so the two act at opposite ends of one pathway.

The vitamin K1 in alfalfa supports carboxylation of osteocalcin and matrix Gla protein, the proteins that bind calcium ions in bone tissue. Calcium taken alongside supplies the mineral those carboxylated proteins act on.

Alfalfa contributes non-heme iron bound in a fibrous plant matrix. Ascorbate reduces that iron to the ferrous form and holds it soluble at intestinal pH, the standard chemistry for improving uptake from a leaf source.

Alfalfa leaf carries a high phylloquinone content, so combining it with supplemental K1 adds to the same vitamin K pool that supports normal clotting factor carboxylation. Anyone tracking a steady vitamin K intake counts both.

K1 from alfalfa and menaquinone both act through the same gamma-glutamyl carboxylase and vitamin K epoxide reductase cycle, so they overlap on clotting factor carboxylation while K2 reaches bone and vascular Gla proteins more readily.

Magnesium is part of the hydroxyapatite lattice and is required by the enzymes that hydroxylate vitamin D, so it works alongside the calcium and vitamin K that alfalfa-based bone formulas supply.

Boron influences calcium and magnesium retention and the hydroxylation of vitamin D metabolites, a separate lever from the vitamin K and mineral content of alfalfa leaf.

Silicon supports collagen cross-linking in the organic bone matrix that mineral then deposits into, a distinct contribution from the calcium and vitamin K side.

Green alfalfa leaf is one of the standard commercial chlorophyll sources, so the two overlap in composition rather than adding separate actions.

Alfalfa saponins bind bile salts and cholesterol in the gut lumen while plant sterols compete with cholesterol for micellar space, so the two act on the same absorption step from different angles.

The saponin and fibre fraction of alfalfa leaf binds divalent minerals in the lumen, so iron taken in the same dose is partly held and less available for uptake.

Alfalfa seeds and sprouts contain L-canavanine, a structural analogue of arginine that competes with arginine for transport and for incorporation by arginyl-tRNA synthetase. Mature dried leaf carries far less canavanine than seed or sprout material, so the form matters. Anyone dosing arginine deliberately should know the two molecules are in competition at the same sites.

Alfalfa leaf is one of the denser plant sources of vitamin K1, the cofactor for gamma-carboxylation of several clotting factors, while nattokinase acts in the opposite direction on fibrin. Taken together they push on clotting from two sides and the net result in a person is unpredictable. This is a flag for combination design, not a claimed benefit.

Alfalfa leaf carries carotenoids including beta-carotene and lutein along with chlorophyll, which is why dried leaf powder is green and why it contributes provitamin A activity to a blend. Adding purified beta-carotene stacks onto that baseline. The compositional point is established; the joint effect is not measured.

Leaf tissue carries tocopherols alongside carotenoids, and alfalfa powder contributes a small amount of both. Supplemental alpha-tocopherol works in the same lipid compartment. The pairing rests on composition and chemistry rather than on a trial of the two together.

Green leaf tissue is a folate source and alfalfa leaf powder contributes some, though the amount per capsule is small next to a supplemental folate dose. The two are additive on intake, nothing more. No interaction beyond that is established.

Alfalfa leaf is potassium-rich as plant tissue generally is, so a leaf powder adds to total potassium intake alongside a supplemental source. The contribution from a typical capsule dose is modest. Worth noting when potassium intake is being counted deliberately.

Alfalfa leaf brings mostly insoluble fibre, which adds faecal bulk, while psyllium is a gel-forming soluble fibre that holds water. Combining them changes stool texture through two different physical routes and raises total fluid requirement. Established fibre physiology; the specific blend has not been trialled.

Inulin is readily fermented by colonic bacteria while alfalfa's fibre is largely lignified and much less fermentable. Pairing them gives one fraction that ferments quickly and one that mostly bulks. The rationale is mechanistic and the combination is untested in people.

Alfalfa is studied heavily as a forage precisely because its fibre shapes microbial fermentation, and rumen studies track shifts in bacterial, archaeal and fungal populations when it is fed. Those are non-human digestive systems with far greater fibre-degrading capacity than a human colon. The pairing is plausible on that basis and unproven for people.

Alfalfa saponins form complexes with sterols and interfere with micelle formation in the gut lumen, which is the same mechanism that carries fat-soluble compounds across the intestinal wall. A carotenoid such as lycopene depends on those micelles for uptake. Separating the doses is the practical response.

Both appear in traditional women's health blends, alfalfa as a nutritive leaf and dang gui as the classical constituent. The pairing is a formulation convention with a long history and thin modern measurement. It is recorded here as practice, not as evidence.

Alfalfa appears in blends positioned for normal blood sugar handling alongside chromium, which participates in insulin signalling. The alfalfa side of that pairing rests on fibre and saponin content rather than on human trials. Low confidence is the honest label.